Faculty profile

Craig Campbell

Back to faculty

Professor/Medical DoctorPaediatricsWestern University

Craig Campbell

Professor/Medical Doctor

Paediatrics

Schulich School of Medicine & Dentistry

Western University

London, Ontario, Canada

ORCID

Supervision signals

Professors usually supervise graduate students in their department's programs.
24 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.
Principal investigator on 3 research grants (3 CIHR), most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,953

Citations

Collaborators

Grants

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile Search on Google Scholar iDORCID

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Western University profile.

Clinical Care Education Neuromuscular Disease Research Network Research

Latest papers

Expanding Vamorolone Treatment Access for Canadians with Duchenne Muscular Dystrophy.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 2026
Neurobehavioral Profiles in Young Steroid-Naive Boys With Duchenne Muscular Dystrophy: A Baseline Data Analysis From the FOR-DMD Trial.
Neurology · 2026
Toward Trial Readiness in Congenital Myotonic Dystrophy: A Longitudinal Cohort Study of Predictors of Motor Function in Childhood.
Neurology. Genetics · 2026

All 90 publications

Latest funding

NMD4C: the neuromuscular network for Canada
CIHR · 2023 · Principal investigator
$1,000,000
Real-World Evidence for Canadian Neuromuscular Disease: Establishing a Framework for National Integration of Patient Reported Outcomes, Clinical Registry Data, Healthcare Utilization and Healthcare Associated Costs
CIHR · 2023 · Co-investigator
$1,597,256
RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network
CIHR · 2023 · Principal investigator
$19,999,843

All 9 grants and awards

90 publications.

Expanding Vamorolone Treatment Access for Canadians with Duchenne Muscular Dystrophy.

Mah JK, Lochmüller H, Ward L, Selby K, Gonorazky H, Sbrocchi AM, Wiles J, McMillan HJ, Campbell C, Mitton K, Worsfold N

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques2026

DOI: 10.1017/cjn.2026.10649 PMID: 42438401

Neurobehavioral Profiles in Young Steroid-Naive Boys With Duchenne Muscular Dystrophy: A Baseline Data Analysis From the FOR-DMD Trial.

Gadaleta G, Geagan C, Schiava M, Riguzzi P, Hendriksen J, Campbell C, McDermott MP, Martens WB, Gregory SJ, Mongini TE, Griggs RC, Guglieri M, FOR-DMD Investigators of the Muscle Study Group

Neurology2026

DOI: 10.1212/wnl.0000000000218094 PMID: 42139655

Toward Trial Readiness in Congenital Myotonic Dystrophy: A Longitudinal Cohort Study of Predictors of Motor Function in Childhood.

Kiefer M, Hartman JM, Berggren KN, Butler A, Jones AS, McIntyre M, Hung M, Carrell S, Hale MA, Campbell C, Sansone VA, Johnson NE

Neurology. Genetics2026

DOI: 10.1212/nxg.0000000000200363 PMID: 41938492

Implementation of a neuromuscular clinical trial network: a rare disease model for enhancing clinical trial readiness, capacity, and access in Canada.

Schellenberg KL, Osman H, Masnata M, Hicks R, Kagan C, Stosic A, Lintern S, Beattie E, Lochmuller H, Campbell C, Mah JK

Orphanet journal of rare diseases2026

DOI: 10.1186/s13023-026-04393-4 PMID: 42192450

Equitable Access to Disease-Modifying Therapies for Canadian Children with SMA and Four SMN2 Copies

McMillan HJ, Gonorazky H, Campbell C, Chrestian N, Crone M, Dowling JJ, Joyal K, Kolski H, Leung E, Mackenzie A

Canadian Journal of Neurological Sciences20256 citations

DOI: 10.1017/cjn.2024.319

Lung Volume Recruitment and Quality of Life in Duchenne Muscular Dystrophy: Secondary Analysis of the STEADFAST Randomized Controlled Trial

Tsampalieros A, McKim D, Barrowman N, Bijelic V, Mah JK, McMillan HJ, Campbell C, Momoli F, Blinder H, McAdam L

Annals of the American Thoracic Society20252 citations

DOI: 10.1513/annalsats.202404-360oc

Patterns of Adherence to Lung Volume Recruitment Therapy Amongst Individuals With Duchenne Muscular Dystrophy: A Secondary Analysis of the STEADFAST Randomized Controlled Trial

Dussah N, McKim DA, Mah JK, McMillan HJ, Campbell C, Bijelić V, Barrowman N, Momoli F, Blinder H, Aaron S

Pediatric Pulmonology20251 citations

DOI: 10.1002/ppul.71357

Respiratory and Bulbar Support in Spinal Muscular Atrophy Type I Treated with Nusinersen.

Gauvreau G, Behlim T, Ng P, Hodgkinson V, Selby K, Mah JK, Kolski H, Castro-Codesal M, Crone M, Leung E, Joyal K, Campbell C, McAdam L, Gonorazky H, McMillan H, McCormick A, O'Connell C, Taillon M, Oskoui M

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques2025

DOI: 10.1017/cjn.2025.74 PMID: 40357918

Neurobehavioral Phenotype of Children With Congenital Myotonic Dystrophy.

Patel N, Berggren KN, Hung M, Bates K, Dixon MM, Bax K, Adams H, Butterfield RJ, Campbell C, Johnson NE

Neurology2024

DOI: 10.1212/wnl.0000000000208115 PMID: 38359368

International collaboration to improve knowledge on myotonic dystrophy type 2.

Peric S, Ivanovic V, Ashley EJ, Esparis B, Campbell C, Wenninger S, Monckton D, Marini-Bettolo C, Walker H, Voháňka S, Cumming K, Łusakowska A, Hodgkinson V, Cosyns M, Rodrigues M, Yiu E, Mazanec R, Stevenson T, Kostera-Pruszczyk A, Korngut L, Jagut M, Schoser B, Forbes R, Poll A, Roxburgh R

Journal of neuromuscular diseases2024

DOI: 10.1177/22143602241290353 PMID: 39973464

NMD4C: the neuromuscular network for Canada

Principal investigatorCIHR2023Network Gr. in Skin Health, Bone Health, and Muscular Dyst. - Muscular Dystrophy

Principal investigators: Lochmüller, Hanns; Osman, Homira; Brais, Bernard; Campbell, Craig Gordon N; Chang, Natasha C; Dowling, James; Gagnon, Cynthia; Gonorazky, Hernan D; Hodgkinson, Victoria; Karamchandani, Jason; Korngut, Lawrence W; Kothary, Rashmi K; Mah, Jean K; O'Connell, Colleen; Patten, Kessen; Rossi, Fabio M; Schellenberg, Kerri; Selby, Kathryn A; Warman Chardon, Jodi

Keywords: Clinical Trial Networks; Networks; Neuromuscular Disease; Open Science; Patient Partnerships; Preclinical Research Resources; Training And Education; Translational Research

$1,000,000

Real-World Evidence for Canadian Neuromuscular Disease: Establishing a Framework for National Integration of Patient Reported Outcomes, Clinical Registry Data, Healthcare Utilization and Healthcare Associated Costs

Co-investigatorCIHR2023Team Grant: Improving Health and Admin Data and Monitor Rare Diseases

Principal investigators: Amin, Reshma; Osman, Homira; Cohen, Eyal; Hodgkinson, Victoria; Jewett, Gordon; Lochmüller, Hanns

Keywords: Health Services Research; Healthcare Service Utilization; Neuromuscular Disease; Registry

$1,597,256

RareKids-CAN: Pediatric Rare Disease Clinical Trials and Treatment Network

Principal investigatorCIHR2023Team Grant: Pediatric Rare Disease Clinical Network

Principal investigators: Lacaze-Masmonteil, Thierry; Anagnostou, Evdokia; Baribeau, Danielle A; Batthish, Michelle; Bernard, Geneviève; Bernier, Francois P; Butcher, Nancy J; Campbell, Craig Gordon N; Cross, Andrea; Dyack, Sarah; Gantt, Soren M; Gravel, Christopher; Haddad, Elie; Heath, Anna; Kelly, Lauren; King, Alexandra; Klassen, Terry P; Knisley, Lisa; Lai, Meng-Chuan; Lewis, Tamorah R; Marwaha, Ashish K; McBride, Kim; Mitchell, John J; Moore Hepburn, Charlotte; Mooser, Vincent E; Myers, Kenneth A; Offringa, Martin; Oskoui, Maryam; Portales-Casamar, Elodie; Pot, Sara; Potter, Elizabeth K; Richer, Lawrence P; Round, Jeff; Stewart, Breanne; Subbarao, Padmaja; Thebaud, Bernard; Turvey, Stuart E; Ward, Leanne M; Wong-Rieger, Durhane; Wright, Nicola A; Yeh, Ann E.

Keywords: Child Health; Data Science; Drug Development; Paediatric Clinical Research Units; Paediatric Clinical Trials; Patient And Public Involvement; Patient Registries; Precision Medicine; Rare Diseases; Real-World Evidence

$19,999,843

Empowering Next-generation Researchers in perinatal and Child Health (ENRICH)

Co-investigatorCIHR2021Tr. Gr: Health Research Training Platform - Human Dev. Child and Youth Health

Principal investigators: Samuel, Susan M; Andrade, Brendan; Archibald, Mandy M; Benchimol, Eric I; Birken, Catherine S; Chafe, Roger E; Chaillet, Nils; Jans, Jop; Keijzer, Richard; King, Alexandra; King, Malcolm; Mandhane, Piush; Poonai, Naveen; Pritchard-Wiart, Lesley; Regnault, Timothy R; Salami, Bukola O; Stinson, Jennifer N; Tersigni, Claudia A; Thomson, Ron; Walsh, Catharine M; Zwicker, Jill G

Keywords: Child; Child Health; Clinician; Equity; Human Development; Life Cycle; Perinatal Health; Scientist; Training; Youth

$2,400,000

NMD4C: An integrated research network for patients, scientists, and clinicians to improve outcomes and access to therapies for patients with neuromuscular disorders in Canada.

Co-investigatorCIHR2019Network Catalyst Grants - Muscular Dystrophy

Principal investigators: Lochmüller, Hanns; Buffone, Teresa; Dowling, James; Warman Chardon, Jodi

Keywords: Genomics; Knowledge Translation; Networks; Neuromuscular Disease; Patient Engagement; Translational Research

$599,992

An innovative registry-based trials platform to improve clinical care, outcomes, and health policy for children with treatable rare diseases

Co-investigatorCIHR2019Operating Grant: SPOR Innovative Clinical Trial Multi-Year Grant

Principal investigators: Potter, Elizabeth K; McCabe, Christopher; Smith, Maureen M; Binik, Ariella; Chakraborty, Pranesh K; Inbar-Feigenberg, Michal; Mitchell, John J; Offringa, Martin; Oskoui, Maryam; Stockler, Sylvia

Keywords: Comparative Effectiveness; Core Outcomes; Genetic Disease; Innovative Clinical Trial; Orphan Therapy; Patient Partnership; Patient-Oriented Outcomes; Pediatrics; Rare Disease; Registry-Based Randomized Trial

$2,754,009

Rescue of microvasculature enhances repair in muscle degenerative disorders

Co-investigatorCIHR2016Project Grant

Principal investigators: Hoffman, Lisa Marie

Keywords: Aberrant Microvasculature; Angiopoietin-1 (Ang-1); Degenerative Muscle Disease; Duchenne Muscular Dystrophy; Fibrosis; Inflammation; Ischemia; Targeted Drug Delivery; Vascular Endothelial Growth Factor (Vegf)

$604,350

Phase I/II clinical trial of myoblast transplantation to Duchenne Muscular Dystrophy patients.

Co-investigatorCIHR2013Operating Grant

Principal investigators: Tremblay, Jacques P

Keywords: Cell Therapy; Cell Transplantation; Clinical Trial; Duchenne Muscular Dystrophy

$462,858

The Canadian Neuromuscular Network (CAN-NMD)

Principal investigatorCIHR2013Network Catalyst Grant: Skeletal Muscle Research

Principal investigators: Korngut, Lawrence W; Campbell, Craig Gordon N; Gagnon, Cynthia; Genge, Angela L; Jasmin, Bernard J; Kothary, Rashmi K; Mah, Jean K; McMillan, Hugh J; Nicolle, Michael W; Warman Chardon, Jodi; Yokota, Toshifumi

Keywords: Clinical Care; Education; Neuromuscular Disease Research Network; Research

$575,614

From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.

Profile data last refreshed on September 26, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.

Something wrong or missing on this profile? Suggest a correction

Craig Campbell

Research

Latest papers

Latest funding

Expanding Vamorolone Treatment Access for Canadians with Duchenne Muscular Dystrophy.

Neurobehavioral Profiles in Young Steroid-Naive Boys With Duchenne Muscular Dystrophy: A Baseline Data Analysis From the FOR-DMD Trial.

Toward Trial Readiness in Congenital Myotonic Dystrophy: A Longitudinal Cohort Study of Predictors of Motor Function in Childhood.

Implementation of a neuromuscular clinical trial network: a rare disease model for enhancing clinical trial readiness, capacity, and access in Canada.

Equitable Access to Disease-Modifying Therapies for Canadian Children with SMA and Four SMN2 Copies

Lung Volume Recruitment and Quality of Life in Duchenne Muscular Dystrophy: Secondary Analysis of the STEADFAST Randomized Controlled Trial

Patterns of Adherence to Lung Volume Recruitment Therapy Amongst Individuals With Duchenne Muscular Dystrophy: A Secondary Analysis of the STEADFAST Randomized Controlled Trial

Respiratory and Bulbar Support in Spinal Muscular Atrophy Type I Treated with Nusinersen.

Neurobehavioral Phenotype of Children With Congenital Myotonic Dystrophy.

International collaboration to improve knowledge on myotonic dystrophy type 2.

Frequent collaborators

Lawrence Korngut

Mark Tarnopolsky

Maryam Oskoui

Angela Genge

Karen Li-mei Choong

Russell Schachar

Anne-Marie Guerguerian

Franco Momoli

Ronit Mesterman

Douglas Fraser

Pranesh Chakraborty

Jan Willem Gorter

Bernard Brais

Sonny Dhanani

Guangyong Zou

Bekim Sadikovic

Nevena Simic

Darcy Fehlings

Natashia Seemann

Hanns Lochmüller

Jodi Warman Chardon